Recaticimab
Product Specifications
CAS Number
2361290-85-7
Target
LDLR, Others
Related Pathways
Metabolism, Others
Purity
0.997
Bioactivity
Recaticimab (SHR-1209) is a humanized monoclonal antibody targeting PCSK9. By binding to PCSK9, Recaticimab promotes LDL receptor stabilization and surface expression on hepatocytes, leading to reduced plasma LDL cholesterol levels. Recaticimab is under study as a therapeutic candidate for hypercholesterolemia and related cardiovascular disorders.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![CD14 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3F5]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
TA811518BM 100 µL
CD14 Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3F5]
Sign In for Pricing
View Details C2405-17F-ML490 100 µL
CD49d (Integrin alpha4, VLA4, LHR, Lymphocyte Homing Receptor) (MaxLight 490) discontinued
Sign In for Pricing
View Details 
MBS2094789-01 0.1 mL
Biotin-Linked Polyclonal Antibody to Osteopetrosis Associated Transmembrane Protein 1 (OSTM1)
Sign In for Pricing
View Details 
MBS2094789-02 0.2 mL
Biotin-Linked Polyclonal Antibody to Osteopetrosis Associated Transmembrane Protein 1 (OSTM1)
Sign In for Pricing
View Details 
MBS2094789-03 0.5 mL
Biotin-Linked Polyclonal Antibody to Osteopetrosis Associated Transmembrane Protein 1 (OSTM1)
Sign In for Pricing
View Details